2.50
Schlusskurs vom Vortag:
$2.49
Offen:
$2.5
24-Stunden-Volumen:
549.64K
Relative Volume:
0.22
Marktkapitalisierung:
$94.58M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-10.58M
KGV:
-2.0833
EPS:
-1.2
Netto-Cashflow:
$-9.21M
1W Leistung:
+2.04%
1M Leistung:
-6.37%
6M Leistung:
+119.30%
1J Leistung:
+152.53%
Microbot Medical Inc Stock (MBOT) Company Profile
Firmenname
Microbot Medical Inc
Sektor
Telefon
908-938-5561
Adresse
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Vergleichen Sie MBOT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MBOT
Microbot Medical Inc
|
2.50 | 94.58M | 0 | -10.58M | -9.21M | -1.20 |
![]()
ISRG
Intuitive Surgical Inc
|
540.60 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
177.27 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
89.30 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
255.88 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
221.22 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2020-01-13 | Bestätigt | H.C. Wainwright | Buy |
2019-12-24 | Bestätigt | H.C. Wainwright | Buy |
2018-01-31 | Eingeleitet | Ladenburg Thalmann | Buy |
Microbot Medical Inc Aktie (MBOT) Neueste Nachrichten
Microbot Medical (MBOT) Secures Key Patent in China | MBOT Stock News - GuruFocus
Microbot Medical Strengthens Global IP Portfolio with Newly Gran - GuruFocus
Microbot Medical Secures Chinese Patent for Robotic System - TipRanks
Microbot Medical receives patent in China for surgical robotics - Investing.com
Microbot Medical Inc. Secures Key Patent in China for LIBERTY Endovascular Robotic System - Nasdaq
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China - GlobeNewswire
Microbot Medical's Surgical Robot Gets Crucial China Patent, Eyes 2.9M Annual Procedures - Stock Titan
Microbot Medical (MBOT) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Microbot Medical expands authorized shares By Investing.com - Investing.com Nigeria
# H.C. Wainwright keeps Buy rating on MICROBOT stock ahead of launch - Investing.com India
Microbot Medical Approves Key Proposals at Annual Meeting - TipRanks
Microbot Medical expands authorized shares - Investing.com
Microbot Medical gears up for Q3 LIBERTY System launch By Investing.com - Investing.com South Africa
Microbot Medical Continues to Strengthen Commercial Capabilities - GuruFocus
Microbot Medical (MBOT) Strengthens Team for LIBERTY System Laun - GuruFocus
Microbot Medical Expands Team Ahead of LIBERTY Launch - TipRanks
Microbot Medical (MBOT) Strengthens Team for LIBERTY System Launch | MBOT Stock News - GuruFocus
Microbot Medical gears up for Q3 LIBERTY System launch - Investing.com
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical Reveals FDA Timeline, Expands Commercial Team for Q3 2025 LIBERTY System Launch - Stock Titan
Microbot Medical (NASDAQ:MBOT) Share Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Microbot Medical set to join Russell Microcap Index - Investing.com India
Microbot Medical (MBOT) to Join Russell Microcap Index | MBOT St - GuruFocus
Microbot Medical set to join Russell Microcap Index By Investing.com - Investing.com South Africa
Microbot Medical Selected in Preliminary List for Russell Microcap Index Inclusion - MarketScreener
Microbot Medical Selected for Preliminary Inclusion to Russell M - GuruFocus
Microbot Medical Selected for Russell Microcap Index - TipRanks
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index - The Manila Times
Microbot Medical (MBOT) to Join Russell Microcap Index | MBOT Stock News - GuruFocus
Microbot Medical Inc. Selected for Preliminary Inclusion in Russell Microcap® Index - Nasdaq
Robotic Medical Device Maker Microbot Medical Gains Russell Index StatusWhat This Means for Investors - Stock Titan
Largest borrow rate increases among liquid names - TipRanks
Microbot Medical (NASDAQ:MBOT) Share Price Passes Above 200-Day Moving Average – Time to Sell? - Defense World
Microbot Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Microbot Medical (MBOT) Projected to Post Earnings on Wednesday - Defense World
Renaissance Technologies LLC Takes $118,000 Position in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Head to Head Survey: Microbot Medical (NASDAQ:MBOT) versus Hypertension Diagnostics (OTCMKTS:HDII) - Defense World
Geode Capital Management LLC Grows Stock Holdings in Microbot Medical Inc. (NASDAQ:MBOT) - Defense World
Cytosorbents (NASDAQ:CTSO) versus Microbot Medical (NASDAQ:MBOT) Financial Analysis - Defense World
Microbot Medical Releases Updated Presentation Materials - TipRanks
Microbot Medical regains Nasdaq compliance with bid price - MSN
MBOTMicrobot Med Inc Latest Stock News & Market Updates - Stock Titan
Microbot Medical bolsters leadership ahead of FDA decision By Investing.com - Investing.com South Africa
Microbot Medical® Bolsters Commercial Leadership Team with the A - GuruFocus
Microbot Medical (MBOT) Strengthens U.S. Leadership Ahead of FDA Decision | MBOT Stock News - GuruFocus
Microbot Medical Strengthens Leadership Ahead of LIBERTY Launch - TipRanks
Microbot Medical bolsters leadership ahead of FDA decision - Investing.com
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers | MBOT Stock News - GuruFocus
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers - GlobeNewswire
Microbot Medical Accelerates FDA Launch Plans: Marketing VP with 15-Year Track Record Leads Commercial Push - Stock Titan
Finanzdaten der Microbot Medical Inc-Aktie (MBOT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):